In NASH patients, decreased IRS1 expression in the liver could lead to T2DM due to impaired glucose metabolism including fasting hyperinsulinemia and postprandial hyperglycemia. Here, IRS1 is linked to metabolic dysfunction-associated steatohepatitis.